199 related articles for article (PubMed ID: 29511113)
1. Blood HER2 and Uromodulin as Causal Mediators of CKD.
Sjaarda J; Gerstein HC; Yusuf S; Treleaven D; Walsh M; Mann JFE; Hess S; Paré G
J Am Soc Nephrol; 2018 Apr; 29(4):1326-1335. PubMed ID: 29511113
[TBL] [Abstract][Full Text] [Related]
2. Mendelian randomization to assess causality between uromodulin, blood pressure and chronic kidney disease.
Ponte B; Sadler MC; Olinger E; Vollenweider P; Bochud M; Padmanabhan S; Hayward C; Kutalik Z; Devuyst O
Kidney Int; 2021 Dec; 100(6):1282-1291. PubMed ID: 34634361
[TBL] [Abstract][Full Text] [Related]
3. Blood CSF1 and CXCL12 as Causal Mediators of Coronary Artery Disease.
Sjaarda J; Gerstein H; Chong M; Yusuf S; Meyre D; Anand SS; Hess S; Paré G
J Am Coll Cardiol; 2018 Jul; 72(3):300-310. PubMed ID: 30012324
[TBL] [Abstract][Full Text] [Related]
4. The value of uromodulin as a new serum marker to predict decline in renal function.
Leiherer A; Muendlein A; Saely CH; Brandtner EM; Geiger K; Fraunberger P; Drexel H
J Hypertens; 2018 Jan; 36(1):110-118. PubMed ID: 28858977
[TBL] [Abstract][Full Text] [Related]
5. A Mendelian Randomization-Based Approach to Identify Early and Sensitive Diagnostic Biomarkers of Disease.
Mohammadi-Shemirani P; Sjaarda J; Gerstein HC; Treleaven DJ; Walsh M; Mann JF; McQueen MJ; Hess S; Paré G
Clin Chem; 2019 Mar; 65(3):427-436. PubMed ID: 30337280
[TBL] [Abstract][Full Text] [Related]
6. Gamma-glutamyltransferase levels, prediabetes and type 2 diabetes: a Mendelian randomization study.
Nano J; Muka T; Ligthart S; Hofman A; Darwish Murad S; Janssen HLA; Franco OH; Dehghan A
Int J Epidemiol; 2017 Oct; 46(5):1400-1409. PubMed ID: 28338987
[TBL] [Abstract][Full Text] [Related]
7. Causal Associations of Obesity With Chronic Kidney Disease and Arterial Stiffness: A Mendelian Randomization Study.
Ye C; Kong L; Zhao Z; Li M; Wang S; Lin H; Xu Y; Lu J; Chen Y; Xu Y; Wang W; Ning G; Bi Y; Xu M; Wang T
J Clin Endocrinol Metab; 2022 Jan; 107(2):e825-e835. PubMed ID: 34448477
[TBL] [Abstract][Full Text] [Related]
8. Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.
Zhang WR; Craven TE; Malhotra R; Cheung AK; Chonchol M; Drawz P; Sarnak MJ; Parikh CR; Shlipak MG; Ix JH;
Ann Intern Med; 2018 Nov; 169(9):610-618. PubMed ID: 30357395
[TBL] [Abstract][Full Text] [Related]
9.
Wang J; Liu L; He K; Gao B; Wang F; Zhao M; Zhang L; On Behalf Of The Chinese Cohort Study Of Chronic Kidney Disease C-Stride
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828293
[TBL] [Abstract][Full Text] [Related]
10. Causal effect between total cholesterol and HDL cholesterol as risk factors for chronic kidney disease: a mendelian randomization study.
Miao L; Min Y; Qi B; Zhu CM; Chen JH; Deng GX; Wang Y; Li JF; Li RS
BMC Nephrol; 2021 Jan; 22(1):35. PubMed ID: 33472594
[TBL] [Abstract][Full Text] [Related]
11. No causal effects of serum urate levels on the risk of chronic kidney disease: A Mendelian randomization study.
Jordan DM; Choi HK; Verbanck M; Topless R; Won HH; Nadkarni G; Merriman TR; Do R
PLoS Med; 2019 Jan; 16(1):e1002725. PubMed ID: 30645594
[TBL] [Abstract][Full Text] [Related]
12. ACE and Type 2 Diabetes Risk: A Mendelian Randomization Study.
Pigeyre M; Sjaarda J; Chong M; Hess S; Bosch J; Yusuf S; Gerstein H; Paré G
Diabetes Care; 2020 Apr; 43(4):835-842. PubMed ID: 32019855
[TBL] [Abstract][Full Text] [Related]
13. HDL Cholesterol, LDL Cholesterol, and Triglycerides as Risk Factors for CKD: A Mendelian Randomization Study.
Lanktree MB; Thériault S; Walsh M; Paré G
Am J Kidney Dis; 2018 Feb; 71(2):166-172. PubMed ID: 28754456
[TBL] [Abstract][Full Text] [Related]
14. Association of Antihypertensive Drug Target Genes With Psychiatric Disorders: A Mendelian Randomization Study.
Chauquet S; Zhu Z; O'Donovan MC; Walters JTR; Wray NR; Shah S
JAMA Psychiatry; 2021 Jun; 78(6):623-631. PubMed ID: 33688928
[TBL] [Abstract][Full Text] [Related]
15. Serum uromodulin-a marker of kidney function and renal parenchymal integrity.
Scherberich JE; Gruber R; Nockher WA; Christensen EI; Schmitt H; Herbst V; Block M; Kaden J; Schlumberger W
Nephrol Dial Transplant; 2018 Feb; 33(2):284-295. PubMed ID: 28206617
[TBL] [Abstract][Full Text] [Related]
16. UMOD-ulating CKD risk: untangling the relationship between urinary uromodulin, blood pressure, and kidney disease.
Turner M; Staplin N
Kidney Int; 2021 Dec; 100(6):1168-1170. PubMed ID: 34802557
[TBL] [Abstract][Full Text] [Related]
17. Immune cell signatures and inflammatory mediators: unraveling their genetic impact on chronic kidney disease through Mendelian randomization.
Hu Y; Hao F; An Q; Jiang W
Clin Exp Med; 2024 May; 24(1):94. PubMed ID: 38703294
[TBL] [Abstract][Full Text] [Related]
18. Serum uromodulin and progression of kidney disease in patients with chronic kidney disease.
Lv L; Wang J; Gao B; Wu L; Wang F; Cui Z; He K; Zhang L; Chen M; Zhao MH
J Transl Med; 2018 Nov; 16(1):316. PubMed ID: 30454063
[TBL] [Abstract][Full Text] [Related]
19. A new missense mutation in UMOD gene leads to severely reduced serum uromodulin concentrations - A tool for the diagnosis of uromodulin-associated kidney disease.
Satanovskij R; Bader A; Block M; Herbst V; Schlumberger W; Haack T; Nockher WA; Heemann U; Renders L; Schmaderer C; Angermann S; Wen M; Meitinger T; Scherberich J; Steubl D
Clin Biochem; 2017 Feb; 50(3):155-158. PubMed ID: 27729211
[TBL] [Abstract][Full Text] [Related]
20. Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression.
Trudu M; Janas S; Lanzani C; Debaix H; Schaeffer C; Ikehata M; Citterio L; Demaretz S; Trevisani F; Ristagno G; Glaudemans B; Laghmani K; Dell'Antonio G; ; Loffing J; Rastaldi MP; Manunta P; Devuyst O; Rampoldi L
Nat Med; 2013 Dec; 19(12):1655-60. PubMed ID: 24185693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
